[Clinical and epidemiological aspects and current recommendations on treatment of genital herpes].
Glad'ko
V V
VV
Akovbian
V A
VA
Masiukova
S A
SA
Zudin
A B
AB
Glad'ko
O V
OV
Egorova
Iu S
IuS
Omarova
M Kh
MKh
D015075:2-Aminopurine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000212:Acyclovir / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000547:Amantadine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use*; D000077595:Famciclovir; D005260:Female; D006287:Health Planning Guidelines; D006558:Herpes Genitalis / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008887:Military Medicine; D008889:Military Personnel; D012426:Russia / Q000453:epidemiology; D000077483:Valacyclovir; D014633:Valine / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000998:Antiviral Agents; D015075:2-Aminopurine; D000547:Amantadine; C004279:tromantadine; D014633:Valine; D000077483:Valacyclovir; D000077595:Famciclovir; D000212:Acyclovir